sodium molybdate(vi) has been researched along with Pituitary Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Albaladejo, V; Andre, J; Morel, Y; Pharaboz, MO | 1 |
| Finnerty, M; Raaka, BM; Samuels, HH; Sun, E | 1 |
2 other study(ies) available for sodium molybdate(vi) and Pituitary Neoplasms
| Article | Year |
|---|---|
Properties of the estrogen receptors contained in the MtTF4 tumor whose growth is inhibited by estradiol: 17 beta-estradiol, 17 alpha-estradiol and DNA bindings.
Topics: Animals; DNA; DNA, Neoplasm; Estradiol; Female; Male; Molybdenum; Pituitary Neoplasms; Rats; Rats, Inbred F344; Receptors, Estrogen; Stereoisomerism; Tritium; Uterus | 1986 |
Effects of molybdate on steroid receptors in intact GH1 cells. Evidence for dissociation of an intracellular 10 S receptor oligomer prior to nuclear accumulation.
Topics: Animals; Cell Line; Cell Nucleus; Centrifugation, Density Gradient; Cytosol; Estradiol; Macromolecular Substances; Molybdenum; Pituitary Neoplasms; Rats; Receptors, Estrogen; Receptors, Glucocorticoid; Triamcinolone Acetonide | 1985 |